84 related articles for article (PubMed ID: 20734403)
1. Clinical significance of serum vascular endothelial growth factor, endostatin, and leptin levels in children with lymphoma.
Okur FV; Karadeniz C; Buyukpamukcu M; Oguz A; Yucel A; Cinaz P; Emir S; Varan A
Pediatr Blood Cancer; 2010 Dec; 55(7):1272-7. PubMed ID: 20734403
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of proangiogenic cytokines in children with lymphomas.
Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
[TBL] [Abstract][Full Text] [Related]
3. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
Kurschat P; Eming S; Nashan D; Krieg T; Mauch C
Br J Dermatol; 2007 Apr; 156(4):653-8. PubMed ID: 17263813
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma.
Bono P; Teerenhovi L; Joensuu H
Cancer; 2003 Jun; 97(11):2767-75. PubMed ID: 12767089
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of endostatin, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy.
Seko Y; Fukuda S; Nagai R
Clin Sci (Lond); 2004 May; 106(5):439-42. PubMed ID: 14965340
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group.
Schips L; Dalpiaz O; Lipsky K; Langner C; Rehak P; Puerstner P; Pummer K; Zigeuner R
Eur Urol; 2007 Jan; 51(1):168-73; discussion 174. PubMed ID: 16844285
[TBL] [Abstract][Full Text] [Related]
7. High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment.
Urbańska-Ryś H; Robak T
Mediators Inflamm; 2003 Aug; 12(4):229-35. PubMed ID: 14514474
[TBL] [Abstract][Full Text] [Related]
8. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
[TBL] [Abstract][Full Text] [Related]
9. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma.
Feldman AL; Alexander HR; Yang JC; Linehan WM; Eyler RA; Miller MS; Steinberg SM; Libutti SK
Cancer; 2002 Oct; 95(8):1637-43. PubMed ID: 12365010
[TBL] [Abstract][Full Text] [Related]
10. Short-term induction of thrombocytopenia delays periodontal healing in rats with periodontal disease: participation of endostatin and vascular endothelial growth factor.
Spolidorio LC; Herrera BS; Coimbra LS; Figueiredo MN; Spolidorio DM; Muscará MN
J Periodontal Res; 2010 Apr; 45(2):184-92. PubMed ID: 19778332
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma.
Poon RT; Ho JW; Tong CS; Lau C; Ng IO; Fan ST
Br J Surg; 2004 Oct; 91(10):1354-60. PubMed ID: 15376182
[TBL] [Abstract][Full Text] [Related]
12. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
[TBL] [Abstract][Full Text] [Related]
13. The effects of growth hormone status on circulating levels of vascular growth factors.
Silha JV; Krsek M; Hana V; Marek J; Weiss V; Jezkova J; Rosicka M; Jarkovska Z; Murphy LJ
Clin Endocrinol (Oxf); 2005 Jul; 63(1):79-86. PubMed ID: 15963066
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between the ratio of serum vascular endothelial growth factor/endostatin and childhood acute leukemia].
Gu JW; Hu ZD; Liu Z
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Jun; 13(6):475-7. PubMed ID: 21672421
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
Holmes CE; Huang JC; Pace TR; Howard AB; Muss HB
Clin Cancer Res; 2008 May; 14(10):3070-6. PubMed ID: 18483373
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
Uematsu S; Higashi T; Nouso K; Kariyama K; Nakamura S; Suzuki M; Nakatsukasa H; Kobayashi Y; Hanafusa T; Tsuji T; Shiratori Y
J Gastroenterol Hepatol; 2005 Apr; 20(4):583-8. PubMed ID: 15836707
[TBL] [Abstract][Full Text] [Related]
17. Serum VEGF as a significant marker of treatment response in hodgkin lymphoma.
Ben Arush MW; Ben Barak A; Maurice S; Livne E
Pediatr Hematol Oncol; 2007 Mar; 24(2):111-5. PubMed ID: 17454776
[TBL] [Abstract][Full Text] [Related]
18. Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia.
Mahmound RA; Abdel-Raouf M
East Mediterr Health J; 2006; 12(1-2):178-87. PubMed ID: 17037236
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serum vascular endothelial growth factor (VEGF) and plasma activity of matrix metalloproteinase (MMP) 2 and 9 in lymphoma-affected dogs.
Gentilini F; Calzolari C; Turba ME; Agnoli C; Fava D; Forni M; Bergamini PF
Leuk Res; 2005 Nov; 29(11):1263-9. PubMed ID: 15893373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
